GILEAD SCIENCES INC
For the period ended Dec 31, 2023. Filed Feb 23, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 23, 2024
GILD$169.32+1.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| December 31, | ||
|---|---|---|
| (in millions, except per share amounts) | 2023 | 2022 |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $6,085 | $5,412 |
| Short-term marketable debt securities | 1,179 | 973 |
| Accounts receivable, net | 4,660 | 4,777 |
| Inventories | 1,787 | 1,507 |
| Prepaid and other current assets | 2,374 | 1,774 |
| Total current assets | 16,085 | 14,443 |
| Property, plant and equipment, net | 5,317 | 5,475 |
| Long-term marketable debt securities | 1,163 | 1,245 |
| Intangible assets, net | 26,454 | 28,894 |
| Goodwill | 8,314 | 8,314 |
| Other long-term assets | 4,792 | 4,800 |
| Total assets | $62,125 | $63,171 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $550 | $905 |
| Accrued rebates | 3,802 | 3,479 |
| Other current liabilities | 5,130 | 4,580 |
| Current portion of long-term debt and other obligations, net | 1,798 | 2,273 |
| Total current liabilities | 11,280 | 11,237 |
| Long-term debt, net | 23,189 | 22,957 |
| Long-term income taxes payable | 2,039 | 3,916 |
| Deferred tax liability | 1,588 | 2,673 |
| Other long-term obligations | 1,280 | 1,179 |
| Commitments and contingencies (Note 13) | ||
| Stockholders’ equity: | ||
| Preferred stock, par value $0.001 per share; 5 shares authorized; none outstanding | — | — |
| Common stock, par value $0.001 per share; 5,600 authorized; 1,246 and 1,247 shares issued and outstanding, respectively | 1 | 1 |
| Additional paid-in capital | 6,500 | 5,550 |
| Accumulated other comprehensive income | 28 | 2 |
| Retained earnings | 16,304 | 15,687 |
| Total Gilead stockholders’ equity | 22,833 | 21,240 |
| Noncontrolling interest | (84) | (31) |
| Total stockholders’ equity | 22,749 | 21,209 |
| Total liabilities and stockholders’ equity | $62,125 | $63,171 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.